{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:47:14Z","timestamp":1794023234633,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Factor XI (FXI) deficiency is an autosomal hemorrhagic disorder characterized by reduced plasma FXI levels. Multiple ancestral variants in the <jats:italic>F11<\/jats:italic> gene have been identified in Ashkenazi Jews and other selected European populations. However, there are few reports of predominant variants in Chinese and\/or East Asian populations. The aim of this study is to characterize the genotypes and phenotypes of FXI deficiency and identify the predominant variants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 41 FXI-deficient patients, 39 exhibited severe FXI defects, considerably more than those with partial defects. The APTT levels showed a negative correlation with FXI activity levels (coefficient=-0.584, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001). Only nine patients experienced mild bleeding, including one partially defective patient and eight severely defective patients. The majority of patients were referred for preoperative screenings (<jats:italic>n<\/jats:italic>\u2009=\u200922) and checkups (<jats:italic>n<\/jats:italic>\u2009=\u200914). Genetic analysis revealed that 90% of the patients had genetic defects, with 2, 16, and 19 cases of heterozygous, homozygous, and compound heterozygous patients, respectively. Seventeen variants were detected in the <jats:italic>F11<\/jats:italic> gene (6 novel), including eleven missense variants, four nonsense variants, and two small deletions scattered throughout the <jats:italic>F11<\/jats:italic>. Of the 11 missense variants, six have not yet been studied for in vitro expression. Protein modeling analyses indicated that all of these variants disrupted local structural stability by altering side-chain orientation and hydrogen bonds. Nine variants, consisting of three missense and six null variants, were detected with a frequency of two or more. The highest allele frequency was observed in p.Q281* (21.25%), p.W246* (17.50%), p.Y369* (12.50%), and p.L442Cfs*8 (12.50%). The former two were variants specific to East Asia, while the remaining two were southeast China-specific variants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our population-based cohort demonstrated that no correlation between the level of FXI activity and the bleeding severity in FXI deficiency. Additionally, the prevalence of FXI deficiency may have been underestimated. The nonsense p.Q281* was the most common variant in southeast China, suggesting a possible founder effect.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03235-5","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T15:19:31Z","timestamp":1717514371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The spectrum of factor XI deficiency in Southeast China: four recurrent variants can explain most of the deficiencies"],"prefix":"10.1186","volume":"19","author":[{"given":"Ke","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langyi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingye","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"3235_CR1","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0049-3848(16)30354-1","volume":"141","author":"C Puy","year":"2016","unstructured":"Puy C, Rigg RA, McCarty OJT. The hemostatic role of factor XI. Thromb Res. 2016;141:S8\u201311. https:\/\/doi.org\/10.1016\/S0049-3848(16)30354-1.","journal-title":"Thromb Res"},{"key":"3235_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.thromres.2017.10.008","volume":"161","author":"BM Mohammed","year":"2018","unstructured":"Mohammed BM, Matafonov A, Ivanov I, Sun M-f, Cheng Q, Dickeson SK, et al. An update on factor XI structure and function. Thromb Res. 2018;161:94\u2013105. https:\/\/doi.org\/10.1016\/j.thromres.2017.10.008.","journal-title":"Thromb Res"},{"issue":"6","key":"3235_CR3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.hoc.2021.07.012","volume":"35","author":"MD Lewandowska","year":"2021","unstructured":"Lewandowska MD, Connors JM, Factor XI, Deficiency. Hematol Oncol Clin North Am. 2021;35(6):1157\u201369. https:\/\/doi.org\/10.1016\/j.hoc.2021.07.012.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"3235_CR4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/jth.15242","volume":"19","author":"Y Hayakawa","year":"2021","unstructured":"Hayakawa Y, Tamura S, Suzuki N, Odaira K, Tokoro M, Kawashima F, et al. Essential role of a carboxyl-terminal \u03b1-helix motif in the secretion of coagulation factor XI. J Thromb Haemost. 2021;19(4):920\u201330. https:\/\/doi.org\/10.1111\/jth.15242.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3235_CR5","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.1111\/hae.13378","volume":"24","author":"V Rimoldi","year":"2018","unstructured":"Rimoldi V, Paraboschi EM, Menegatti M, Peyvandi F, Salomon O, Duga S, et al. Molecular investigation of 41 patients affected by coagulation factor XI deficiency. Haemophilia. 2018;24(2):E50\u20135. https:\/\/doi.org\/10.1111\/hae.13378.","journal-title":"Haemophilia"},{"issue":"1","key":"3235_CR6","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1111\/hae.12835","volume":"22","author":"M Ahmadinejad","year":"2016","unstructured":"Ahmadinejad M, Alavi S, Ebadi M, Rashidi A, Tabatabaei M, Rezvani A. Combined high molecular weight Kininogen and factor XI deficiency. Haemophilia. 2016;22(1):E60\u20131. https:\/\/doi.org\/10.1111\/hae.12835.","journal-title":"Haemophilia"},{"issue":"4","key":"3235_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/hae.12628","volume":"21","author":"C Santoro","year":"2015","unstructured":"Santoro C, Di Mauro R, Baldacci E, De Angelis F, Abbruzzese R, Barone F, et al. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre. Haemophilia. 2015;21(4):496\u2013501. https:\/\/doi.org\/10.1111\/hae.12628.","journal-title":"Haemophilia"},{"issue":"7","key":"3235_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/17474086.2016.1191944","volume":"9","author":"AP Wheeler","year":"2016","unstructured":"Wheeler AP, Gailani D. Why factor XI deficiency is a clinical concern. Expert Rev Hematol. 2016;9(7):629\u201337. https:\/\/doi.org\/10.1080\/17474086.2016.1191944.","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"3235_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/atvbaha.115.306954","volume":"36","author":"RS Ganor","year":"2016","unstructured":"Ganor RS, Harats D, Schiby G, Gailani D, Levkovitz H, Avivi C, et al. Factor XI Deficiency protects against atherogenesis in apolipoprotein E\/Factor XI double knockout mice. Arterioscler Thromb Vasc Biol. 2016;36(3):475\u201381. https:\/\/doi.org\/10.1161\/atvbaha.115.306954.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3235_CR10","doi-asserted-by":"publisher","unstructured":"Kossmann S, Lagrange J, Jaeckel S, Jurk K, Ehlken M, Schoenfelder T, et al. Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension. Sci Transl Med. 2017;9(375). https:\/\/doi.org\/10.1126\/scitranslmed.aah4923.","DOI":"10.1126\/scitranslmed.aah4923"},{"key":"3235_CR11","doi-asserted-by":"publisher","unstructured":"Sillen M, Declerck PJ. Thrombin activatable fibrinolysis inhibitor (TAFI): an updated narrative review. Int J Mol Sci. 2021;22(7). https:\/\/doi.org\/10.3390\/ijms22073670.","DOI":"10.3390\/ijms22073670"},{"issue":"6","key":"3235_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/mbc.0000000000001010","volume":"32","author":"H Xie","year":"2021","unstructured":"Xie H, Liu M, Zou A, Xie Y, Ye J. A novel mutation (Leu60Pro) in a Chinese pedigree with hereditary factor XI deficiency. Blood Coagul Fibrinolysis. 2021;32(6):401\u20135. https:\/\/doi.org\/10.1097\/mbc.0000000000001010.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"3235_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564\u20139. https:\/\/doi.org\/10.1002\/humu.22981.","journal-title":"Hum Mutat"},{"key":"3235_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","volume":"7","author":"U Seligsohn","year":"2009","unstructured":"Seligsohn U. Factor XI deficiency in humans. J Thromb Haemost. 2009;7:84\u20137. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03395.x.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3235_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1586\/17474086.2015.1039978","volume":"8","author":"G Lippi","year":"2015","unstructured":"Lippi G, Pasalic L, Favaloro EJ. Detection of mild inherited disorders of blood coagulation: current options and personal recommendations. Expert Rev Hematol. 2015;8(4):527\u201342. https:\/\/doi.org\/10.1586\/17474086.2015.1039978.","journal-title":"Expert Rev Hematol"},{"key":"3235_CR16","doi-asserted-by":"publisher","unstructured":"Kuder H, Dickeson SK, Brooks MB, Kehl A, M\u00fcller E, Gailani D, et al. A common missense variant causing factor XI Deficiency and increased bleeding tendency in Maine Coon cats. Genes. 2022;13(5). https:\/\/doi.org\/10.3390\/genes13050792.","DOI":"10.3390\/genes13050792"},{"issue":"2","key":"3235_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000528583","volume":"146","author":"S Jiang","year":"2023","unstructured":"Jiang S, Chen Y, Liu M, Zeng M, Yang L, Jin Y, et al. Gene Variants in two families with inherited coagulation factor XI Deficiency and Identification of mutations. Acta Haematol. 2023;146(2):106\u201316. https:\/\/doi.org\/10.1159\/000528583.","journal-title":"Acta Haematol"},{"issue":"1","key":"3235_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1182\/blood-2003-10-3530","volume":"104","author":"DV Kravtsov","year":"2004","unstructured":"Kravtsov DV, Wu WM, Meijers JCM, Sun MF, Blinder MA, Dang TP, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood. 2004;104(1):128\u201334. https:\/\/doi.org\/10.1182\/blood-2003-10-3530.","journal-title":"Blood"},{"key":"3235_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcmd.2016.01.004","volume":"58","author":"Y Shao","year":"2016","unstructured":"Shao Y, Cao Y, Lu Y, Dai J, Ding Q, Wang X, et al. Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China. Blood Cells Mol Dis. 2016;58:29\u201334. https:\/\/doi.org\/10.1016\/j.bcmd.2016.01.004.","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"3235_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ajh.10396","volume":"74","author":"WY Au","year":"2003","unstructured":"Au WY, Cheung JW, Lam CCK, Kwong YL. Two factor XI mutations in a Chinese family with factor XI deficiency. Am J Hematol. 2003;74(2):136\u20138. https:\/\/doi.org\/10.1002\/ajh.10396.","journal-title":"Am J Hematol"},{"issue":"2","key":"3235_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/mbc.0000000000000861","volume":"31","author":"F Lin","year":"2020","unstructured":"Lin F, Weng MS, Wu JR, Fang SH, Yang LY. Gene variants in four pedigrees with hereditary coagulation factor XI deficiency and one novel mutation identification. Blood Coagul Fibrinolysis. 2020;31(2):160\u20134. https:\/\/doi.org\/10.1097\/mbc.0000000000000861.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"3235_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12185-020-02883-0","volume":"112","author":"HY Lin","year":"2020","unstructured":"Lin HY, Lin CY, Hung MH, Kuo SF, Lin JS, Shen MC. Characterization of hereditary factor XI deficiency in Taiwanese patients: identification of three novel and two common mutations. Int J Hematol. 2020;112(2):169\u201375. https:\/\/doi.org\/10.1007\/s12185-020-02883-0.","journal-title":"Int J Hematol"},{"issue":"1","key":"3235_CR23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3181\/00379727-82-20057","volume":"82","author":"RL Rosenthal","year":"1953","unstructured":"Rosenthal RL, Dreskin OH, Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med. 1953;82(1):171\u20134.","journal-title":"Proc Soc Exp Biol Med"},{"key":"3235_CR24","doi-asserted-by":"publisher","unstructured":"Dorgalaleh A, Bahraini M, Shams M, Parhizkari F, Dabbagh A, Naderi T, et al. Molecular basis of rare congenital bleeding disorders. Blood Rev. 2023;59. https:\/\/doi.org\/10.1016\/j.blre.2022.101029.","DOI":"10.1016\/j.blre.2022.101029"},{"issue":"4","key":"3235_CR25","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1182\/blood-2017-04-780148","volume":"130","author":"R Asselta","year":"2017","unstructured":"Asselta R, Paraboschi EM, Rimoldi V, Menegatti M, Peyvandi F, Salomon O, et al. Exploring the global landscape of genetic variation in coagulation factor XI deficiency. Blood. 2017;130(4):E1\u20136. https:\/\/doi.org\/10.1182\/blood-2017-04-780148.","journal-title":"Blood"},{"issue":"6","key":"3235_CR26","doi-asserted-by":"publisher","first-page":"E488","DOI":"10.1111\/hae.13356","volume":"23","author":"J Esteban","year":"2017","unstructured":"Esteban J, de la Morena-Barrio ME, Salloum-Asfar S, Padilla J, Minano A, Roldan V, et al. High incidence of FXI deficiency in a Spanish Town caused by 11 different mutations and the first duplication of <\u2009i\u2009>\u2009F11: results from the Yecla study. Haemophilia. 2017;23(6):E488\u201396. https:\/\/doi.org\/10.1111\/hae.13356.","journal-title":"Haemophilia"},{"issue":"2","key":"3235_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/blood.V85.2.429.bloodjournal852429","volume":"85","author":"O Shpilberg","year":"1995","unstructured":"Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi jews (type II) is also prevalent in Iraqi jews, who represent the ancient gene pool of jews. Blood. 1995;85(2):429\u201332. https:\/\/doi.org\/10.1182\/blood.V85.2.429.bloodjournal852429.","journal-title":"Blood"},{"issue":"7","key":"3235_CR28","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1182\/blood.V99.7.2448","volume":"99","author":"A Zivelin","year":"2002","unstructured":"Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, et al. Factor XI deficiency in French basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood. 2002;99(7):2448\u201354. https:\/\/doi.org\/10.1182\/blood.V99.7.2448.","journal-title":"Blood"},{"issue":"6","key":"3235_CR29","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1538-7836.2004.00723.x","volume":"2","author":"PHB Bolton-Maggs","year":"2004","unstructured":"Bolton-Maggs PHB, Peretz H, Butler R, Mountford R, Keeney S, Zacharski L, et al. A common ancestral mutation (C128X) occurring in 11 non-jewish families from the UK with factor XI deficiency. J Thromb Haemost. 2004;2(6):918\u201324. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00723.x.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3235_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1538-7836.2004.00554.x","volume":"2","author":"F Qu\u00e9lin","year":"2004","unstructured":"Qu\u00e9lin F, Trossa\u00ebrt A, Sigaud M, Mazancourt PDE, Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France.: seven novel mutations, including an ancient Q88X mutation. J Thromb Haemost. 2004;2(1):71\u20136. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00554.x.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3235_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1399-0004.2011.01732.x","volume":"82","author":"J Kim","year":"2012","unstructured":"Kim J, Song J, Lyu CJ, Kim YR, Oh SH, Choi YC, et al. Population-specific spectrum of the F11 mutations in koreans: evidence for a founder effect. Clin Genet. 2012;82(2):180\u20136. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01732.x.","journal-title":"Clin Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03235-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03235-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03235-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T15:25:10Z","timestamp":1717514710000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03235-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3235"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03235-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"13 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}